Androgen decline in patients with nonobstructive azoospemia after microdissection testicular sperm extraction. 2008

Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

OBJECTIVE Microdissection testicular sperm extraction (TESE) is the ideal procedure for obtaining a high sperm retrieval rate. However, few studies of the postoperative endocrinologic course have been reported. We evaluated the endocrinologic course for 1 year after microdissection TESE and compared the results with the testicular histologic findings. METHODS A total of 69 patients with nonobstructive azoospermia who had undergone microdissection TESE were included. The overall sperm retrieval rate was 50.7%. The endocrinologic data were evaluated before and 3, 6, and 12 months after surgery. RESULTS The mean serum total testosterone level in patients with hypospermatogenesis decreased postoperatively and had recovered by 12 months (102%). The mean serum total testosterone level in patients with Klinefelter syndrome also decreased postoperatively but had recovered to only 50% of the baseline value at 12 months after microdissection TESE. At 12 months, the mean serum total testosterone level in patients with maturation arrest was 93.1% of the preoperative level and that in patients with Sertoli cell-only syndrome was 80.6% of the preoperative level. The preoperative serum luteinizing hormone and follicle-stimulating hormone in patients with Klinefelter syndrome was high and remained high after microdissection TESE. The mean serum luteinizing hormone and follicle-stimulating hormone levels in patients with hypospermatogenesis did not change, and those in patients with maturation arrest increased continuously after microdissection TESE. Finally, those in patients with Sertoli cell-only syndrome increased up to 6 months after surgery and decreased after that. CONCLUSIONS The results of our study indicate that long-term endocrinologic follow-up is necessary after microdissection TESE, particularly for patients with Klinefelter syndrome to detect hypogonadism.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D007713 Klinefelter Syndrome A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.). 48,XXYY Syndrome,49,XXXXY Syndrome,Klinefelter Syndrome, Variants,Klinefelter's Syndrome,XXXY Males,XXY Syndrome,XXY Trisomy,Xxyy Syndrome,Klinefelter Syndromes,Klinefelter Syndromes, Variants,Klinefelters Syndrome,Syndrome, Klinefelter,Syndrome, Klinefelter's,Syndrome, Variants Klinefelter,Syndrome, XXY,Syndrome, Xxyy,Syndromes, Klinefelter,Syndromes, Variants Klinefelter,Syndromes, XXY,Syndromes, Xxyy,Trisomies, XXY,Trisomy, XXY,XXXY Male,XXY Syndromes,XXY Trisomies,Xxyy Syndromes
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D013079 Sperm Maturation The maturing process of SPERMATOZOA after leaving the testicular SEMINIFEROUS TUBULES. Maturation in SPERM MOTILITY and FERTILITY takes place in the EPIDIDYMIS as the sperm migrate from caput epididymis to cauda epididymis. Maturation of Spermatozoa,Maturation, Sperm,Spermatozoa Maturation
D013091 Spermatogenesis The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA. Spermatocytogenesis,Spermiogenesis

Related Publications

Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
October 2009, The Journal of urology,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
September 2002, The Journal of urology,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
March 2011, The Journal of urology,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
February 2013, The Journal of urology,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
August 2010, Fertility and sterility,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
February 2013, Fertility and sterility,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
August 2008, Andrologia,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
February 2024, Medicine,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
September 2013, The Journal of urology,
Shingo Takada, and Akira Tsujimura, and Tomohiro Ueda, and Yasuhiro Matsuoka, and Tetsuya Takao, and Yasushi Miyagawa, and Minoru Koga, and Masami Takeyama, and Yoshio Okamoto, and Kiyomi Matsumiya, and Hideki Fujioka, and Norio Nonomura, and Akihiko Okuyama
February 2018, Andrologia,
Copied contents to your clipboard!